Business

Launch of Barbara T. Murphy Endowed Lectureship

Launch of Barbara T. Murphy Endowed Lectureship.

articleVerici Dx PlcNovember 8, 20214/company/verici-dx-plc/news/launch-of-barbara-t-murphy-endowed-lectureship
Launch of Barbara T. Murphy Endowed Lectureship

About this update from Verici Dx Plc

[{"type":"text","content":"\n \n \n \n RNS Number : 6279R\n Verici Dx PLC\n 08 November 2021\n  \n \n \n \n Verici Dx plc\n \n \n (\"Verici Dx\" or the \"Company\") \n \n \n  \n \n Launch of Barbara T. Murphy Endowed Lectureship\n \n  \n \n \n Launch of lecture\n \n commemorating Verici Dx co-founder and former Board member\n \n \n  \n \n with\n American Society of Nephrology\n supported by Verici Dx Plc, Renalytix plc and in conjunction with the American Society of Transplantation\n \n , starting at ASN Kidney Week 2022 \n \n \n  \n Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces that it has signed an agreement with Renalytix plc (NASDAQ: RLNX AIM: RENX) and the American Society of Transplantation (\"AST\"), to establish and sponsor collectively the Barbara T. Murphy Endowed Lectureship (\"The Murphy Lectureship\"), commemorating Dr. Barbara T. Murphy, Verici Dx's late co-founder and Board member.  Under the Murphy Lectureship, a lecture will be given each year in perpetuity during the American Society of Nephrology (\"ASN\") Kidney Week.  Dr. Murphy was also a co-founder and Board member of Renalytix plc and a long serving member of the ASN, on whose Council she served and of which she was President-Elect; she was also a former president of the AST and former co-chair of its Public Policy committee.\n  \n The lectureship, which will begin at ASN Kidney Week being held in November 2022, will honour Dr. Murphy's legacy as a renowned leader in transplant immunology and medicine by recognising advances in kidney transplantation.\n  \n Each lecture will feature a significant figure in kidney transplant immunology and medicine, focusing on kidney risk pre-transplant and transplant care. The lecturers may be physicians, scientists, or represent any other discipline provided they meet the award criteria.  During her career, Dr. Murphy catalysed considerable activity across multiple centers of excellence and this collaborative approach generated a significant body of insights into the immunological mechanisms involved in transplant rejection and the scope for improving transplant care.  The Murphy Lectureship in her honour is intended to foster continuing co-operation across different fields of expertise in support of further patient gains in trans...

More updates from Verici Dx Plc